Home Cart 0 Sign in  

[ CAS No. 1364488-67-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1364488-67-4
Chemical Structure| 1364488-67-4
Structure of 1364488-67-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1364488-67-4 ]

Related Doc. of [ 1364488-67-4 ]

Alternatived Products of [ 1364488-67-4 ]

Product Details of [ 1364488-67-4 ]

CAS No. :1364488-67-4 MDL No. :MFCD28099816
Formula : C25H27Cl2N3O4 Boiling Point : -
Linear Structure Formula :- InChI Key :OTUBDDRFPQLPKD-UHFFFAOYSA-N
M.W : 504.41 Pubchem ID :56943013
Synonyms :
Chemical Name :Ethyl 3-(2-(tert-butylamino)-1-(N-(4-chlorobenzyl)formamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate

Calculated chemistry of [ 1364488-67-4 ]

Physicochemical Properties

Num. heavy atoms : 34
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.32
Num. rotatable bonds : 11
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 134.03
TPSA : 91.5 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.69 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.61
Log Po/w (XLOGP3) : 5.19
Log Po/w (WLOGP) : 4.79
Log Po/w (MLOGP) : 3.5
Log Po/w (SILICOS-IT) : 5.6
Consensus Log Po/w : 4.54

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.84
Solubility : 0.000733 mg/ml ; 0.00000145 mol/l
Class : Moderately soluble
Log S (Ali) : -6.86
Solubility : 0.0000699 mg/ml ; 0.000000139 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.28
Solubility : 0.00000265 mg/ml ; 0.0000000053 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.89

Safety of [ 1364488-67-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1364488-67-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1364488-67-4 ]

[ 1364488-67-4 ] Synthesis Path-Downstream   1~2

  • 2
  • [ 1364488-67-4 ]
  • ethyl 3-(2-(tert-butylamino)-1-(N-(4-chlorobenzyl)formamido)-2-oxoethyl)-6-chloro-1H-indoIe-2-carboxylate [ No CAS ]
  • ethyl 3-(2-(tert-butylamino)-1-(N-(4-chlorobenzyl)formamido)-2-oxoethyl)-6-chloro-1H-indoIe-2-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With RegisCell (#784106, OD); In ethanol; carbon dioxide; at 40.0℃;Resolution of racemate;Purification / work up; Inventive compounds according to Formulae I or II that contain a chiral center can be resolved using chiral supercritical fluid column chromatography (SFC). For instance, the two enantiomers of compound 81 were obtained in 20 milligram (mg) amounts using SFC.Experiments were performed using the analytical SFC-MS Resolution System (Waters 2998 Photodiode Array Detector, Waters 3100 Mass Detector), and the preparative TharSFC System (Waters 2998 Photodiode Array Detector). Both analytical and preparative SFC columns were operating at 40 C in Analytical-2-Prep Column Oven. Carbon dioxide supplied by BDS 500 Gas Delivery System was used as the primary mobile phase for SFC.The enantiomers of 81 were separated by preparative SFC. Enantiomer 1 had a retention time of 1.55 minutes (tR = 1.55 min), while the second enantiomer eluted at 2.07 minutes (tR = 2.07 min). Preparative SFC was performed using RegisCell (No.784106, OD), column that has 5 muMu particles, and an internal diameter (i.d), of 250 mm x 21.1 mm. The flow rate was 100 ml/minute and an isocratic elution was performed using 20% ethanol. The injection volume was maintained at 500 mu. The concentration of stock solution was 100 mg/mL.Representative chromatographic traces for the separation of enantiomers of compound 81 using (A) analytical and (B) preparative SFC is shown in Figure 3.
Same Skeleton Products
Historical Records